Growth Metrics

Petmed Express (PETS) Cash from Financing Activities (2016 - 2025)

Petmed Express has reported Cash from Financing Activities over the past 16 years, most recently at -$231000.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 225.35% year-over-year to -$231000.0; the TTM value through Dec 2025 reached -$266000.0, down 37.11%, while the annual FY2025 figure was -$181000.0, 98.54% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was -$231000.0 at Petmed Express, down from -$30000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at -$1000.0 in Q4 2024 and troughed at -$6.3 million in Q3 2023.
  • A 5-year average of -$3.5 million and a median of -$6.0 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: soared 99.75% in 2023 and later tumbled 225.35% in 2025.
  • Year by year, Cash from Financing Activities stood at -$6.1 million in 2021, then decreased by 0.54% to -$6.1 million in 2022, then soared by 99.75% to -$15000.0 in 2023, then soared by 93.33% to -$1000.0 in 2024, then tumbled by 23000.0% to -$231000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for PETS at -$231000.0 in Q3 2025, -$30000.0 in Q2 2025, and -$5000.0 in Q1 2025.